Baidu
map

2016中国医院竞争力•县级(12个)专科排名

2017-03-26 庄一强 艾力彼观察

中国史上首次对中国县级医院专科(外科系列:普通外科、骨科、泌尿外科、神经外科、ICU、妇产科,内科系列心血管内科、呼吸内科、消化内科、神经内科、肿瘤科、儿科)进行排名评价,得出县级外科20强所属医院位于县级医院综合名次前50强,分布在江苏、山东、浙江、广东、湖北、湖南、四川、吉林这八个省份。县级外科20强虽科研能力普遍偏弱,但规模配置、服务能力、医疗质量患者安全等方面表现较出色,能较好地完成本级医

中国史上首次对中国县级医院专科(外科系列:普通外科、骨科、泌尿外科、神经外科、ICU、妇产科,内科系列血管内科、呼吸内科、消化内科、神经内科、肿瘤科、儿科)进行排名评价,得出县级外科20强所属医院位于县级医院综合名次前50强,分布在江苏、山东、浙江、广东、湖北、湖南、四川、吉林这八个省份。县级外科20强虽科研能力普遍偏弱,但规模配置、服务能力、医疗质量患者安全等方面表现较出色,能较好地完成本级医院需要承担的医疗任务。县级内科20强均来自县级医院综合排名的前60强,来自江苏、山东、浙江、广东、湖北、四川、湖南、广西、河北、吉林十个省份;20强专科具备较高的医疗质量和患者安全;存在床位使用率高,高学历医师比例低等问题。



由榜单可以看出医疗资源分布不均,如何全面提升我国县级医院专科能力,是亟待解决的问题。外科发展具有可复制性的优势,医院可优先发展外科,最终全面提升县级专科能力,承担起县域居民常见病、多发病诊疗、危急重症抢救与疑难病转诊的任务。

县级榜单名次靠前的医院甚至比很多地级城市医院的人员配置和技术水平更高,但也有很多县级医院现阶段发展仍较落后。从6个专科各项指标的最大值、最小值就可以看出,虽然“中国医院竞争力·县级专科”20强现阶段发展都较好,但专科第1名与专科第20名尚且有较大差距的,更别说未能进入20强榜单的专科了。全面提升县级医院综合能力,还任重而道远。














版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
    2017-04-06 wxl882001

    浏览一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
    2017-03-26 医之美

    评审标准是啥

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
    2017-03-26 喜婷

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1764663, encodeId=d39f1e64663e2, content=<a href='/topic/show?id=d5cee56412b' target=_blank style='color:#2F92EE;'>#竞争力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75641, encryptionId=d5cee56412b, topicName=竞争力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693637755061, createdName=12498cbcm12(暂无昵称), createdTime=Tue May 09 22:42:00 CST 2017, time=2017-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715265, encodeId=cdb21e15265af, content=<a href='/topic/show?id=235220e0106' target=_blank style='color:#2F92EE;'>#专科#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20701, encryptionId=235220e0106, topicName=专科)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=894231925290, createdName=12498ebem29暂无昵称, createdTime=Mon Feb 12 01:42:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=185552, encodeId=afce185552cc, content=浏览一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Thu Apr 06 13:11:12 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182882, encodeId=910718288285, content=评审标准是啥, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuGYaG3DtvrLVJ7HhIECWX4ll1PfCD3ibABpkrZH09K1t3LBib16Twic4GC4YC5eeQ29w9rDgacd9FSH/0, createdBy=f3ae2037787, createdName=医之美, createdTime=Sun Mar 26 18:20:53 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182863, encodeId=fb5a18286354, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKfcA3xZnott5TnvcnGrdO58uy0RP4NgPa0Qz8FibHlolypPLEmmcGicSPMJVWQKbRkAY8UVZlFRtGw/132, createdBy=c67f2030047, createdName=喜婷, createdTime=Sun Mar 26 14:18:18 CST 2017, time=2017-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182835, encodeId=19cd18283595, content=学习了,发展好, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Mar 26 13:02:09 CST 2017, time=2017-03-26, status=1, ipAttribution=)]
    2017-03-26 1ddf0692m34(暂无匿称)

    学习了,发展好

    0

相关资讯

比共享单车更暴露人性的,是医院的病房

“医院的墙壁聆听了比教堂更多的祷告”。

“十三五”养老体系规划发布 2020年35%的二级以上综合医院设立老年病科

3月6日,国务院印发《“十三五”国家老龄事业发展和养老体系建设规划》(以下简称《规划》),明确了“十三五”时期促进老龄事业发展和养老体系建设的指导思想、基本原则、发展目标和主要任务。《规划》指出,有条件的地区可将部分公立医院转为康复、护理等机构。提高基层医疗卫生机构康复护理床位占比,积极开展家庭医生签约服务,为老年人提供连续的健康管理和医疗服务。到2020年,35%以上的二级以上综合医院设立老

全球**自助式手术衣问世

据新加坡《联合早报》3月14日报道,日本大阪大学参与的一个研究团队3月13日表示,全球首款无须他人协助穿上和脱下的手术衣将在4月面世,这将有助于加强医院感染防控。

为什么有医院拒绝“互联网+”?

健康医疗大数据项目频频获得投资人青睐,但仍有相当一部分医院,并没有采用互联网企业的信息化软件。技术不成熟,工具同质化严重,企业对医院不了解,不能完全满足临床需求,医院担心数据安全,患者隐私泄露等问题,都是目前亟待解决的突出难题。

感恩洛克菲勒家族 创办了中国理想的医院

人们常说,“一部协和史,就是半部中国医学史”,如果说近代中国医学史上,有什么人物对其影响巨大时,那一定离不开洛克菲勒家族。据英国路透社3月20日报道,美国亿万富豪戴维·洛克菲勒在睡梦中安然辞世,享年101岁。1914年,专注慈善的洛克菲勒基金会刚成立不久,便派出了中国考察团,对社会状况、教育、卫生、医学校、医院进行了细致的考察。考察团成员都是美国顶尖的医学教育专家,包括约翰·霍普金斯医学院院长韦尔

继检验科和骨科之后 这个科室成了反腐重点

据江苏省常州市武进区人民检察院发布的消息,近日,常州市武进区人民检察院依法以涉嫌受贿罪对武进人民医院心内科原副主任翁伟进立案侦查,并采取刑事拘留强制措施,目前该案正在进一步侦查中。这是常州市今年落马的第三家医院心血管科室负责人。继检验科和骨科遭遇“清洗”之后,这次轮到心血管科室了?今年1月,据最高检网消息,常州市金坛区人民检察院依法对常州市金坛区中医医院九病区(心脑血管)主任陈月明以涉嫌受贿罪立案

Baidu
map
Baidu
map
Baidu
map